Edesa Biotech, Inc. — Form D

Edesa Biotech, Inc. of MARKHAM, A6, a company, filed a Form D exempt-offering notice with the SEC on 2026-06-26. The offering totals $3.5M, of which $3.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (47)

Showing 25 of 47 people.

NameRoleLocation
Michael BrooksRelated PersonMarkham, A6
Joan ChypyhaRelated PersonMarkham, A6
David LiuRelated PersonMarkham, A6
Sean MacDonaldRelated PersonMarkham, A6
Patrick MarshallRelated PersonMarkham, A6
Pardeep NijhawanRelated PersonMarkham, A6
Charles OlsonRelated PersonMarkham, A6
Carlo SistilliRelated PersonMarkham, A6
Peter WeilerRelated PersonMarkham, A6
Jennifer ChaoDirectorOakville, A6
Patrick MarshallDirectorMarkham, A6
Sean MacDonaldDirectorMarkham, A6
Pardeep NijhawanDirectorMarkham, A6
Pardeep NijhawanExecutive OfficerMarkham, A6
Stephen LemieuxExecutive OfficerMARKHAM, A6
Charles OlsonDirectorMarkham, A6
Frank OakesDirectorMARKHAM, A6
David LiuDirectorMarkham, A6
Joan ChypyhaDirectorMarkham, A6
Michael BrooksExecutive OfficerMarkham, A6
Carlo SistilliDirectorMarkham, A6
Kathi NiffeneggerExecutive OfficerMarkham, A6
Paul PayDirectorMarkham, A6
Lorin JohnsonDirectorRaleigh, NC
Mark A McPartlandExecutive OfficerSouth San Francisco, CA

Other filings by this issuer (8)

FiledFormOfferingSold
2025-02-14D$15.0M$15.0M
2022-04-05D
2016-07-21D$6.8M$6.8M
2013-10-03D/A$12.0M$12.0M
2013-09-03D$12.0M
2013-04-11D$1.6M$1.6M
2013-01-15D$505K$505K
2012-10-31D$1.0M$1.0M

More